N-Desalkylflurazepam (also known as norflurazepam) is a benzodiazepine analog and an active metabolite of several other benzodiazepine drugs including flurazepam, flutoprazepam, fludiazepam, midazolam, flutazolam, quazepam, and ethyl loflazepate.
It is long-acting, prone to accumulation, and binds unselectively to the various benzodiazepine receptor subtypes.
It has been sold as a designer drug from 2016 onward.
Desalkylflurazepam, also known as N-desalkyl-2-oxoquazepam, is a long-acting metabolite of the benzodiazepine drug flurazepam. Flurazepam is sold under the trade names Dalmane and Dalmadorm for the treatment of mild to moderate insomnia.